Agreement signedPublished 16 May 2023
Jazz Pharmaceuticals /
Zymeworks Zanidatamab
Jazz Pharmaceuticals agrees to buy Zymeworks Zanidatamab
- Terms
- Not stated
- Stage
- Agreement signed
01 / BuyerJazz Pharmaceuticals
02 / TargetZymeworks Zanidatamab
What happened
Jazz Pharmaceuticals agreed to acquire Zymeworks Zanidatamab, according to a filing dated May 16, 2023.
The source
Everything on this page comes from the source below.
01
Source · Original source
Jazz Pharmaceuticals agrees to buy Zymeworks Zanidatamab
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Announced
The source this page is built from.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly